The new product offering will supply global life science researchers with performance and reliability in multi-fragment ...

CHICAGO, IL / ACCESSWIRE / September 22, 2023 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative ...

The All Cosmos Bio-Tech EPS (TTM) is 2.04. All Cosmos Bio-Tech (4148) reported sales of 829.80, net income of 68.76, and EPS of 1.02 for the latest quarter. What was All Cosmos Bio-Tech's net income ...

Cosmo Bio USA provides quality life science products from leading Japanese manufacturers, to laboratories, research institutes, life-science education and testing organizations throughout North ...

1 Day 4148 -0.24% DJIA -0.20% S&P Mid Cap 400 -0.54% Basic Materials/Resources -0.42% Shih Hao Peng Chairman, Chief Executive Officer & GM All Cosmos Bio-Tech Holding Corp. Tau Boon Lim Director All ...

ZURICH, ZURICH, SWITZERLAND, August 2, 2023/EINPresswire.com/ -- InSphero AG and Cosmo Bio Co., Ltd. are announcing a strategic partnership to distribute InSphero’s ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Explore the TYO:3386 financials. Find the Cosmo Bio financial statements for a comprehensive overview of the company’s financial health. This summary highlights critical numbers from key financial ...

Japan Year Ended December 31 GROUP 2025 2024 Revenue Y10.77 bln Y10.04 bln Operating Profit Y343.00 mln Y318.00 mln Pretax Profit Y489.00 mln Y364.00 mln Net Profit Y337.00 mln Y262.00 mln Per share ...